Cargando…

Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease

To identify predictors of 36-month follow-up quality of life (QoL) outcome after bilateral subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson’s disease (PD). In this ongoing, prospective, multicenter international study (Cologne, Manchester, London) including 73 patients undergoing ST...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jost, Stefanie T., Visser-Vandewalle, Veerle, Rizos, Alexandra, Loehrer, Philipp A., Silverdale, Monty, Evans, Julian, Samuel, Michael, Petry-Schmelzer, Jan Niklas, Sauerbier, Anna, Gronostay, Alexandra, Barbe, Michael T., Fink, Gereon R., Ashkan, Keyoumars, Antonini, Angelo, Martinez-Martin, Pablo, Chaudhuri, K. Ray, Timmermann, Lars, Dafsari, Haidar S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187358/ https://www.ncbi.nlm.nih.gov/pubmed/34103534 http://dx.doi.org/10.1038/s41531-021-00174-x

Ejemplares similares

Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson’s disease
por: Dafsari, Haidar S., et al.
Publicado: (2020)

Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease
por: Sauerbier, Anna, et al.
Publicado: (2021)

Gender gap in deep brain stimulation for Parkinson’s disease
por: Jost, Stefanie T., et al.
Publicado: (2022)

Changes in Parkinson’s disease sleep symptoms and daytime somnolence after bilateral subthalamic deep brain stimulation in Parkinson’s disease
por: Kharkar, Siddharth, et al.
Publicado: (2018)

SOP: acute hyperkinetic movement disorders
por: Sauerbier, Anna, et al.
Publicado: (2023)

A Randomized, Double-Blinded Crossover Trial of Short Versus Conventional Pulse Width Subthalamic Deep Brain Stimulation in Parkinson’s Disease
por: Petry-Schmelzer, Jan Niklas, et al.
Publicado: (2022)

Selecting the Most Effective DBS Contact in Essential Tremor Patients Based on Individual Tractography
por: Petry-Schmelzer, Jan Niklas, et al.
Publicado: (2020)

Correction: Petry-Schmelzer et al. Selecting the Most Effective DBS Contact in Essential Tremor Patients Based on Individual Tractography. Brain Sci. 2020, 10, 1015
por: Petry-Schmelzer, Jan Niklas, et al.
Publicado: (2021)

Parkinson’s Disease Stigma Questionnaire (PDStigmaQuest): Development and Pilot Study of a Questionnaire for Stigma in Patients with Idiopathic Parkinson’s Disease
por: Stopic, Vasilija, et al.
Publicado: (2023)

Thalamic Deep Brain Stimulation in Essential Tremor Plus Is as Effective as in Essential Tremor
por: Steffen, Julia K., et al.
Publicado: (2020)

PSA and VIM DBS efficiency in essential tremor depends on distance to the dentatorubrothalamic tract
por: Dembek, Till A., et al.
Publicado: (2020)

Personalised Advanced Therapies in Parkinson’s Disease: The Role of Non-Motor Symptoms Profile
por: Leta, Valentina, et al.
Publicado: (2021)

Probabilistic mapping of deep brain stimulation effects in essential tremor
por: Dembek, Till A, et al.
Publicado: (2016)

Deep brain stimulation of the posterior subthalamic area and the thalamus in patients with essential tremor: study protocol for a randomized controlled pilot trial
por: Barbe, Michael T., et al.
Publicado: (2016)

DiODe v2: Unambiguous and Fully-Automated Detection of Directional DBS Lead Orientation
por: Dembek, Till A., et al.
Publicado: (2021)

Deep brain stimulation of the subthalamic nucleus modulates sensitivity to decision outcome value in Parkinson’s disease
por: Seymour, Ben, et al.
Publicado: (2016)

Pulse duration settings in subthalamic stimulation for Parkinson's disease
por: Steigerwald, Frank, et al.
Publicado: (2017)

Long-term benefit of pallidal deep brain stimulation in a patient with VPS16-associated dystonia
por: Petry-Schmelzer, Jan Niklas, et al.
Publicado: (2022)

Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients: an European multicentre survey
por: Rizos, A., et al.
Publicado: (2020)

Accelerometric Classification of Resting and Postural Tremor Amplitude
por: van der Linden, Christina, et al.
Publicado: (2023)

Outcomes from deep brain stimulation targeting subthalamic nucleus and caudal zona incerta for Parkinson’s disease
por: Mostofi, Abteen, et al.
Publicado: (2019)

The effects of Thalamic Deep Brain Stimulation on speech dynamics in patients with Essential Tremor: An articulographic study
por: Mücke, Doris, et al.
Publicado: (2018)

Microstructural alterations predict impaired bimanual control in Parkinson’s disease
por: Loehrer, Philipp A., et al.
Publicado: (2022)

Involvement of the subthalamic nucleus in engagement with behaviourally relevant stimuli
por: Sauleau, Paul, et al.
Publicado: (2009)

Distribution and impact on quality of life of the pain modalities assessed by the King’s Parkinson’s disease pain scale
por: Martinez-Martin, Pablo, et al.
Publicado: (2017)

Frequency specific activity in subthalamic nucleus correlates with hand bradykinesia in Parkinson's disease
por: Tan, Huiling, et al.
Publicado: (2013)

Human subthalamic nucleus–medial frontal cortex theta phase coherence is involved in conflict and error related cortical monitoring
por: Zavala, Baltazar, et al.
Publicado: (2016)

Decoding gripping force based on local field potentials recorded from subthalamic nucleus in humans
por: Tan, Huiling, et al.
Publicado: (2016)

Complementary roles of different oscillatory activities in the subthalamic nucleus in coding motor effort in Parkinsonism()
por: Tan, Huiling, et al.
Publicado: (2013)

Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
por: Qamar, MA, et al.
Publicado: (2017)

Subthalamic nucleus beta and gamma activity is modulated depending on the level of imagined grip force
por: Fischer, Petra, et al.
Publicado: (2017)

Patterns of Cell Activity in the Subthalamic Region Associated with the Neuroprotective Action of Near-Infrared Light Treatment in MPTP-Treated Mice
por: Shaw, Victoria E., et al.
Publicado: (2012)

Alternating Modulation of Subthalamic Nucleus Beta Oscillations during Stepping
por: Fischer, Petra, et al.
Publicado: (2018)

Author Correction: Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
por: Qamar, M. A., et al.
Publicado: (2023)

Subthalamic beta-targeted neurofeedback speeds up movement initiation but increases tremor in Parkinsonian patients
por: He, Shenghong, et al.
Publicado: (2020)

Distinct mechanisms mediate speed-accuracy adjustments in cortico-subthalamic networks
por: Herz, Damian M, et al.
Publicado: (2017)

Non-oral dopaminergic therapies for Parkinson’s disease: current treatments and the future
por: Ray Chaudhuri, K, et al.
Publicado: (2016)

Myofibrillar myopathy: a rare but important differential diagnosis of camptocormia in a patient with Parkinson’s Disease
por: Petry-Schmelzer, Jan Niklas, et al.
Publicado: (2023)

The aperiodic exponent of subthalamic field potentials reflects excitation/inhibition balance in Parkinsonism
por: Wiest, Christoph, et al.
Publicado: (2023)

Evoked Resonant Neural Activity in subthalamic local field potentials reflects basal ganglia network dynamics
por: Wiest, Christoph, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gtknchj5bhcrsvop7pmjvkrsua